Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Sevoflurane on Rocuronium Neuromuscular Blockade in Chemotherapy Patients
NCT04965532Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Sep 2021
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of sevoflurane in chemotherapy-induced toxicity (4 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoint: Muscle relaxation recovery index. Status: unknown.
02
Drugs
sevoflurane
03
Conditions
chemotherapy-induced toxicity
Beyond the preview
Go deeper on NCT04965532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04965532.